Dipòsit Digital de Documents de la UAB 8 registres trobats  La cerca s'ha fet en 0.02 segons. 
1.
28 p, 430.7 KB Drug-related deaths in hospital inpatients : A retrospective cohort study / Montané, Eva (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Arellano, Ana Lucía (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Sanz, Yolanda (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Roca, Josep (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Farré, Magi (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)
Aims: To determine the incidence of drug-related deaths (DRD) in a university hospital in 2015, to describe their characteristics, and to discover risk factors of DRD. Methods: An analytic and retrospective cohort study. [...]
2018 - 10.1111/bcp.13471
British Journal of Clinical Pharmacology, Vol. 84 Núm. 3 (march 2018) , p. 542-552  
2.
25 p, 1.1 MB Epidemiology of drug-related deaths in European hospitals : A systematic review and meta-analysis of observational studies / Montané Esteva, Eva (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Castells Cervello, Xavier (Universitat de Girona. Departament de Ciències Mèdiques)
Aims: To perform a systematic review of observational studies on the epidemiology of drug-related death (DRD) in patients requiring hospitalisation or while hospitalised (hospital-acquired DRD). Methods: We conducted a systematic review of observational studies investigating the occurrence rate of DRD episodes among deceased inpatients. [...]
2021 - 10.1111/bcp.14799
British Journal of Clinical Pharmacology, Vol. 87 Núm. 10 (october 2021) , p. 3659-3671  
3.
5 p, 2.1 MB Effect of age and sex on acenocoumarol requirements / Arboix Arzo, Margarita (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Laporte Rosselló, Joan-Ramón (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Frati, Maria Elisa (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Rutllan, M. (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)
A group of 690 patients (337 males and 353 females) on long-term acenocoumarol therapy was studied. 62. 8% of the values of the prothrombin ratio were within the chosen therapeutic range (1. 8 to 2. [...]
1984 - 10.1111/j.1365-2125.1984.tb02494.x
British Journal of Clinical Pharmacology, Vol. 18 Núm. 4 (october 1984) , p. 475-479  
4.
6 p, 2.3 MB The potentiation of acenocoumarol anticoagulant effect by amiodarone / Arboix Arzo, Margarita (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Frati, Maria Elisa (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Laporte Rosselló, Joan-Ramón (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)
Out of 690 patients (337 males and 353 females) on long-term acenocoumarol therapy, 80 (35 males and 45 females) were taking amiodarone. Forty patients had started amiodarone treatment while being treated with acenocoumarol. [...]
1984 - 10.1111/j.1365-2125.1984.tb02476.x
British Journal of Clinical Pharmacology, Vol. 18 Núm. 3 (september 1984) , p. 355-360  
5.
12 p, 2.3 MB Monitoring of gene expression in tacrolimus-treated de novo renal allograft recipients facilitates individualized immunosuppression : results of the IMAGEN study / Sommerer, Claudia (Heidelberg University Hospital (Alemanya)) ; Brunet, M. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Budde, K. (Charité University Hospital Berlin) ; Millán, O. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Guirado, Luis (Institut d'Investigació Biomèdica Sant Pau) ; Glander, P. (Charité University Hospital Berlin) ; Meuer, S. (Institute of Immunology. University Hospital Heidelberg) ; Zeier, M. (Heidelberg University Hospital (Alemanya)) ; Giese, Thomas (Heidelberg University Hospital (Alemanya))
Aims: Calcineurin inhibitors (CNI) have a small therapeutic window, and drug monitoring is required. Pharmacokinetic monitoring does not correlate sufficiently with clinical outcome. Therefore, the expression of nuclear factor of activated T cells (NFAT)-regulated genes in the peripheral blood has been suggested as a potentially useful immune monitoring tool to optimize CNI therapy. [...]
2021 - 10.1111/bcp.14794
British Journal of Clinical Pharmacology, Vol. 87 Núm. 10 (october 2021) , p. 3851-3862  
6.
4 p, 794.2 KB Biosimilar and interchangeable : inseparable scientific concepts? / Mora Pérez, Fernando de (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Balsa, Alejandro ; Cornide-Santos, María (Hospital General de Segovia) ; Carrascosa, José Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Marsal, Sara (Hospital Universitari Vall d'Hebron) ; P. Gisbert, Javier (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; Abad, Miguel-Angel (Hospital Virgen del Puerto) ; Duarte, Rafael (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Wiechmann, Michael ; Martínez Cabeza de Vaca, Rafael (Sandoz Iberia) ; Universitat Autònoma de Barcelona
2019 - 10.1111/bcp.14089
British Journal of Clinical Pharmacology, Vol. 85 (september 2019) , p. 2460-2463  
7.
16 p, 1.2 MB Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008-2015) : A cross-national drug utilization study / Ibáñez, Luisa (Universitat Autònoma de Barcelona) ; Sabaté, Mònica (Universitat Autònoma de Barcelona) ; Vidal Guitart, Xavier (Universitat Autònoma de Barcelona) ; Ballarín, Elena (Hospital Universitari Vall d'Hebron) ; Rottenkolber, Marietta (Klinikum der Universität München) ; Schmiedl, Sven (Helios University Hospital Wuppertal) ; Heeke, Andreas (AOK NORDWEST) ; Huerta, Consuelo (Agencia Española de Medicamentos y Productos Sanitarios) ; Martin Merino, Elisa (Agencia Española de Medicamentos y Productos Sanitarios) ; Montero, Dolores (Agencia Española de Medicamentos y Productos Sanitarios) ; Leon-Muñoz, Luz María (Agencia Española de Medicamentos y Productos Sanitarios) ; Gasse, Christiane (Aarhus University) ; Moore, Nicholas (INSERM CIC1401, Université de Bordeaux) ; Droz, Cécile (INSERM CIC1401, Université de Bordeaux) ; Lassalle, Régis (INSERM CIC1401, Université de Bordeaux) ; Aakjær, Mia (University of Copenhagen) ; Andersen, Morten (University of Copenhagen) ; De Bruin, Marie Louise (University of Copenhagen) ; Groenwold, Rolf (Leiden University Medical Center) ; van den Ham, Hendrika A. (Universiteit Utrecht, David de Wiedgebouw) ; Souverein, Patrick (Universiteit Utrecht, David de Wiedgebouw) ; Klungel, Olaf (University Medical Center Utrecht) ; Gardarsdottir, Helga (University of Iceland) ; Universitat Autònoma de Barcelona ; Hospital Universitari Vall d'Hebron
To estimate the incidence of direct oral anticoagulant drug (DOAC) use in patients with nonvalvular atrial fibrillation and to describe user and treatment characteristics in 8 European healthcare databases representing 6 European countries. [...]
2019 - 10.1111/bcp.14071
British Journal of Clinical Pharmacology, Vol. 85 (september 2019) , p. 2524-2539  
8.
11 p, 1.6 MB Bilastine vs. hydroxyzine : occupation of brain histamine H-receptors evaluated by positron emission tomography in healthy volunteers / Farre, Magi (Institut Hospital del Mar d'Investigacions Mèdiques) ; Pérez-Mañá, Clara (Institut Hospital del Mar d'Investigacions Mèdiques) ; Papaseit, Esther (Institut Hospital del Mar d'Investigacions Mèdiques) ; Menoyo, Esther (Institut Hospital del Mar d'Investigacions Mèdiques) ; Pérez, Marta (Institut Hospital del Mar d'Investigacions Mèdiques) ; Martin, Soraya (Institut Hospital del Mar d'Investigacions Mèdiques) ; Bullich, Santiago (Molecular Imaging Centre, CRC Corporación) ; Rojas, Santiago (Molecular Imaging Centre, CRC Corporación) ; Herance, José Raul (Molecular Imaging Centre, CRC Corporación) ; Trampal, Carlos (Molecular Imaging Centre, CRC Corporación) ; Labeaga, Luis (FAES FARMA S.A) ; Valiente, Román (FAES FARMA S.A) ; Universitat Autònoma de Barcelona
A close correlation exists between positron emission tomography (PET)-determined histamine H-receptor occupancy (HRO) and the incidence of sedation. Antihistamines with HRO <20% are classified as non-sedating. [...]
2014 - 10.1111/bcp.12421
British Journal of Clinical Pharmacology, Vol. 78 (october 2014) , p. 970-980  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.